Emerging anxiolytics
- 5 November 2007
- journal article
- review article
- Published by Taylor & Francis in Emerging Drugs
- Vol. 12 (4) , 541-554
- https://doi.org/10.1517/14728214.12.4.541
Abstract
(2007). Emerging anxiolytics. Expert Opinion on Emerging Drugs: Vol. 12, No. 4, pp. 541-554. doi: 10.1517/14728214.12.4.541Keywords
This publication has 106 references indexed in Scilit:
- GABAergic Control of Adult Hippocampal Neurogenesis in Relation to Behavior Indicative of Trait Anxiety and Depression StatesJournal of Neuroscience, 2007
- Augmentation Treatment of Psychotherapy for Anxiety Disorders with D‐CycloserineCNS Drug Reviews, 2006
- Role of corticotropin releasing factor in anxiety disorders: A translational research perspectiveHormones and Behavior, 2006
- A Review and Meta-Analysis of the Genetic Epidemiology of Anxiety DisordersAmerican Journal of Psychiatry, 2001
- The Effects of Chronic Medical Conditions on Work Loss and Work CutbackJournal of Occupational and Environmental Medicine, 2001
- Neuroanatomical Hypothesis of Panic Disorder, RevisedAmerican Journal of Psychiatry, 2000
- Adverse Reactions of Selective Serotonin Reuptake InhibitorsDrug Safety, 1999
- The Impact of Psychiatric Disorders on Labor Market OutcomesILR Review, 1997
- Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patientsJournal of Sex & Marital Therapy, 1997
- Enhanced Aggressive Behavior in Mice Lacking 5-HT 1B ReceptorScience, 1994